Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

(2017) S L Asa et al.   ENDOCRINE-RELATED CANCER

Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers

(2017) Metaxia Tampourlou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification

(2016) W. Saeger et al.   ENDOCRINE PATHOLOGY

Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients

(2016) Marialaura Del Basso De Caro et al.   NEUROSURGICAL REVIEW

Post-surgical management of non-functioning pituitary adenoma

(2015) Christine Cortet-Rudelli et al.   ANNALES D ENDOCRINOLOGIE

Invasive, Atypical and Aggressive Pituitary Adenomas and Carcinomas

(2015) Aydin Sav et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

A Prognostic Clinicopathologic Classification of Pituitary Endocrine Tumors

(2015) Gérald Raverot et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

(2015) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis

(2015) Sabrina Chiloiro et al.   NEUROENDOCRINOLOGY

Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications

(2015) Christian P. Miermeister et al.   Acta Neuropathologica Communications

Aggressive pituitary adenomas—diagnosis and emerging treatments

(2014) Antonio Di Ieva et al.   Nature Reviews Endocrinology

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

(2013) Jacqueline Trouillas et al.   ACTA NEUROPATHOLOGICA

The Role of Mediators of Cell Invasiveness, Motility, and Migration in the Pathogenesis of Silent Corticotroph Adenomas

(2013) Ozgur Mete et al.   ENDOCRINE PATHOLOGY

Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment

(2012) Gérald Raverot et al.   CLINICAL ENDOCRINOLOGY

A classification tree approach for pituitary adenomas

(2012) Alberto Righi et al.   HUMAN PATHOLOGY

Resistance to Somatostatin Analogs in Acromegaly

(2011) Annamaria Colao et al.   ENDOCRINE REVIEWS

Therapy of aggressive pituitary tumors

(2011) Annamaria Colao et al.   EXPERT OPINION ON PHARMACOTHERAPY

Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease

(2010) Gérald Raverot et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up

(2010) Gérald Raverot et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Atypical pituitary adenomas: incidence, clinical characteristics, and implications

(2010) Gabriel Zada et al.   JOURNAL OF NEUROSURGERY

Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas

(2008) Roger Gejman et al.   HUMAN PATHOLOGY